YCF-70736-59075
3 vaccinations
4 coded responses
38 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 025 / MA
- Registered
- 2021-04-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-04
Registered in v-safe
-
2021-04-05
Dose 1 — Pfizer-BioNTech
- 2021-04-05
-
2021-04-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-07
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
-
2021-04-19
Survey response — day 14, dose 1MedDRA: Arthralgia, Joint stiffness, Muscle fatigue — Feeling: GoodFree text: Not exactly new. Lingering Joint tightness / pain with normal activities. Muscle fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-26
Dose 2 — Pfizer-BioNTech
- 2021-04-26
-
2021-04-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-29
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body achesAdult check-in
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-11
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-06-07
-
2021-07-26
Survey response — 3 months, dose 2MedDRA: Heavy menstrual bleeding, Menstrual disorder, Menstruation delayed, Oligomenorrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Disruption of menstrual cycle including late /early arrival, duration (longer than usual) symptoms (severe) and flow (heavier than normal). Prior to vaccination, predictable to the day, very few if any symptoms, three day duration, predicted flow.MedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-10-25
-
2021-10-31
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-31
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-02
Survey response — days 1–6 daily, dose 3MedDRA: Musculoskeletal stiffness — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesFree text: Stiffness in the neckMedDRA releases: 2024-11 · check-in free text available
-
2021-11-03
Health check-in — days 1–6 daily, dose 3Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-11-04
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-14
- 2021-11-21
- 2021-11-28
- 2021-12-07
- 2021-12-12
-
2022-02-01
Survey response — 3 months, dose 3MedDRA: Impaired healing, Skin disorder, Skin ulcer — Feeling: GoodFree text: Blemishes or sores on the head hairline and neck that don't seem to heal quickly or reoccur in the same place after a few weeksMedDRA releases: 2024-11 · check-in free text available
- 2022-05-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-05 | Pfizer-BioNTech | |
| 2 | 2021-04-26 | Pfizer-BioNTech | |
| 3 | 2021-10-31 | Pfizer-BioNTech | Flu |
Free text
Release 7 — day 14, dose 1
Symptoms: Not exactly new. Lingering Joint tightness / pain with normal activities. Muscle fatigue
Release 9 — 3 months, dose 2
Symptoms: Disruption of menstrual cycle including late /early arrival, duration (longer than usual) symptoms (severe) and flow (heavier than normal). Prior to vaccination, predictable to the day, very few if any symptoms, three day duration, predicted flow.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Stiffness in the neck
Release 11 — 3 months, dose 3
Symptoms: Blemishes or sores on the head hairline and neck that don't seem to heal quickly or reoccur in the same place after a few weeks
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Heavy menstrual bleeding | ✓ | · | ✓ |
| SD | Impaired healing | · | · | ✓ |
| SD | Joint stiffness | ✓ | ✓ | ✓ |
| SD | Menstrual disorder | ✓ | · | ✓ |
| SD | Menstruation delayed | ✓ | · | ✓ |
| SD | Muscle fatigue | ✓ | ✓ | ✓ |
| SD | Oligomenorrhoea | ✓ | · | ✓ |
| SD | Skin disorder | · | · | ✓ |
| SD | Skin ulcer | · | · | ✓ |
| SRO | Musculoskeletal stiffness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release